HomeMDRX • OTCMKTS
Veradigm Inc
$4.15
Apr 17, 8:10:00 PM GMT-4 · USD · OTCMKTS · Disclaimer
StockUS listed securityUS headquartered
Previous close
$4.20
Day range
$4.15 - $4.24
Year range
$3.80 - $11.80
Market cap
449.30M USD
Avg Volume
226.72K
P/E ratio
-
Dividend yield
-
Primary exchange
OTCMKTS
In the news
Financials
Income Statement
Revenue
Net income
(USD)2022Y/Y change
Revenue
588.02M1.83%
Operating expense
327.97M59.87%
Net income
-86.46M-161.95%
Net profit margin
-14.70-160.82%
Earnings per share
0.49-65.73%
EBITDA
51.23M-48.39%
Effective tax rate
68.61%—
Total assets
Total liabilities
(USD)2022Y/Y change
Cash and short-term investments
446.59M234.13%
Total assets
1.50B-34.89%
Total liabilities
487.22M-48.75%
Total equity
1.02B—
Shares outstanding
108.26M—
Price to book
0.44—
Return on assets
-0.64%—
Return on capital
-0.82%—
Net change in cash
(USD)2022Y/Y change
Net income
-86.46M-161.95%
Cash from operations
115.56M250.83%
Cash from investing
585.15M4,708.90%
Cash from financing
-444.91M-71.87%
Net change in cash
256.25M173.60%
Free cash flow
121.01M150.83%
About
Veradigm Inc. is a publicly traded American company that provides physician practices, hospitals, and other healthcare providers with practice management and electronic health record technology. Veradigm also provides products for patient engagement and care coordination, as well as financial and analytics technology. The company has more than 180,000 physician users and has products in 2,700 hospitals and 13,000 extended care organizations. The company formally changed its name from Allscripts to Veradigm in January 2023. Wikipedia
Founded
1986
Employees
2,450
Discover more
You may be interested in
This list is generated from recent searches, followed securities, and other activity. Learn more

All data and information is provided “as is” for personal informational purposes only, and is not intended to be financial advice nor is it for trading purposes or investment, tax, legal, accounting or other advice. Google is not an investment adviser nor is it a financial adviser and expresses no view, recommendation or opinion with respect to any of the companies included in this list or any securities issued by those companies. Please consult your broker or financial representative to verify pricing before executing any trades. Learn more
People also search for
Search
Clear search
Close search
Google apps
Main menu